Richard Scranton, Chief Scientific Officer at Pacira BioSciences, Inc. (PCRX), sold 15,510 shares at $43.21 ($670K) on 2019-06-03, disclosed to the SEC on 2019-06-05.
Open-market sale of $670k PCRX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PCRX | SELL | 2018-06-06 | $45K | — | Filing → |